On August 27, the United States Court of Appeals for the Federal Circuit (CAFC) reversed and remanded a decision of the U.S. District Court for the District of Delaware in Baxalta Inc. v. Genentech, Inc. The CAFC reversed the district court’s claim construction of the terms “antibody” and “antibody fragment” in Baxalta’s patent claims and remanded for proceedings consistent with the correct constructions. Read More>>
Categories Courts, District Courts, Federal Circuit, IP News, IPWatchdog Articles, Litigation, Patents, CAFC, claim construction, intellectual property, patent, Patent Litigation, patents, written description
